Abstract
Objective
To observe the effect of acupuncture at Quchi (LI11) on the serum interleukin-2 (IL-2) level and the severity of uremic pruritus (UP) in hemodialysis patients.
Methods
Sixty hemodialysis patients with UP were randomized into an acupuncture group and a control group, with 30 cases in each group. In the acupuncture group, patients were treated with acupuncture at Quchi (LI11) twice a week for six weeks. In the control group, each patient received a placebo treatment (sham acupuncture). Before and after the intervention, the pruritis severity was examined using a 5-D scale, and the serum IL-2 level was measured using an enzyme-linked immunosorbent assay kit.
Results
There were no statistically significant differences in the demographic or clinical factors between the control group and the acupuncture group at baseline. The reduction in pruritus severity in patients was more significant in the acupuncture group (P=0.027). Acupuncture therapy also significantly decreased the serum IL-2 level in the patients (P=0.011). Throughout the acupuncture procedures, the incidence of pain and mild bleeding was 3.6% and 2.5%, respectively.
Conclusion
Six-week acupuncture treatment at Quchi (LI11) can effectively decrease the severity of UP and the serum IL-2 level. Large-scale, long-duration, and multi-center studies are needed to fully understand the role of IL-2 in inflammation and neuroimmune stimulation during acupuncture.
【摘要】
目的
观察针刺曲池穴对血液透析患者血清白细胞介素2(IL-2)水平及尿毒症瘙痒(UP)程度的影响。
方法
将60例尿素症瘙痒的血液透析患者随机分为针刺组和对照组, 每组30例。针刺组患者接受针刺曲池治疗, 每周2次, 共治疗6周。对照组患者接受安慰剂治疗(假针刺)。干预前后用5-D量表评价瘙痒程度, 用酶联免疫吸附测定试剂盒检测血清IL-2水平。
结果
在人口统计及临床因素方面对照组与针刺组基线数据无统计学差异。针刺组患者的瘙痒减轻程度明显高于对照组(P=0.027)。同时, 针刺疗法能显著降低血清IL-2水平(P=0.011)。全部针刺过程中, 疼痛和轻微出血的发生率分别为3.6%和2.5%。
结论
针刺曲池6周有效地降低了UP严重程度及血清IL-2水平。为全面了解针刺时IL-2在炎症和神经免疫刺激中的作用, 需要开展大样本、长周期、多中心的研究。
Similar content being viewed by others
References
PISONI R L, WIKSTRÖM B, ELDER S J, AKIZAWA T, ASANO Y, KEEN M L, SARAN R, MENDELSSOHN D C, YOUNG E W, PORT F K. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant, 2006, 21(12): 3495–3505.
MATHUR V S, LINDBERG J, GERMAIN M, BLOCK G, TUMLIN J, SMITH M, GREWAL M, MCGUIRE D; ITCH National Registry Investigators. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol, 2010, 5(8): 1410–1419.
ARAMWIT P, OUPPATHAM S. Uremic Pruritus: Its Prevalence, Pathophysiology and Management. Updates in Hemodialysis. London: IntechOpen Limited, 2015: 19–42.
SHIRAZIAN S, AINA O, PARK Y, CHOWDHURY N, LEGER K, HOU L, MIYAWAKI N, MATHUR V S. Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis, 2017, 10: 11–26.
MIHAI S, CODRICI E, POPESCU I D, ENCIU A M, ALBULESCU L, NECULA L G, MAMBET C, ANTON G, TANASE C. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res, 2018, 2018: 2180373.
AMORE A, COPPO R. Immunological basis of inflammation in dialysis. Nephrol Dial Transplant, 2002, Suppl 8: 16–24.
METTANG T, PAULI-MAGNUS C, ALSCHER D M. Uraemic pruritus-new perspectives and insights from recent trials. Nephrol Dial Transplant, 2002, 17(9): 1558–1563.
DILLON S R, SPRECHER C, HAMMOND A, BILSBOROUGH J, ROSENFELD-FRANKLIN M, PRESNELL S R, HAUGEN H S, MAURER M, HARDER B, JOHNSTON J, BORT S, MUDRI S, KUIJPER J L, BUKOWSKI T, SHEA P, DONG D L, DASOVICH M, GRANT F J, LOCKWOOD L, LEVIN S D, LECIEL C, WAGGIE K, DAY H, TOPOUZIS S, KRAMER J, KUESTNER R, CHEN Z, FOSTER D, PARRISH-NOVAK J, GROSS J A. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol, 2004, 5(7): 752–760.
YOSIPOVITCH G, DUQUE M I, PATEL T S, ISHIUJI Y, GUZMAN-SANCHEZ D A, DAWN A G, FREEDMAN B I, CHAN Y H, CRUMRINE D, ELIAS P M. Skin barrier structure and function and their relationship to pruritus in end-stage renal disease. Nephrol Dial Transplant, 2007, 22(11): 3268–3272.
COMBS S A, TEIXEIRA J P, GERMAIN M J. Pruritus in kidney disease. Semin Nephrol, 2015, 35(4): 383–391.
WAHLGREN C F, TENGVALL LINDER M, HÄGERMARK O, SCHEYNIUS A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res, 1995, 287(6): 572–580.
NAKAMURA M, TOYODA M, MOROHASHI M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol, 2003, 149(4): 718–730.
GASPARI A A, LOTZE M T, ROSENBERG S A, STERN J B, KATZ S I. Dermatologic changes associated with interleukin 2 administration. JAMA, 1987, 258(12): 1624–1629.
IKOMA A, STEINHOFF M, STÄNDER S, YOSIPOVITCH G, SCHMELZ M. The neurobiology of itch. Nat Rev Neurosci, 2006, 7(7): 535–547.
CARR M N, TORRES S M, KOCH S N, REITER L V. Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs. Vet Dermatol, 2009, 20(2): 105–110.
BUDDENKOTTE J, STEINHOFF M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy, 2010, 65(7): 805–821.
NOWAK D A, YEUNG J. Diagnosis and treatment of pruritus. Can Fam Physician, 2017, 63(12): 918–924.
NARITA I, IGUCHI S, OMORI K, GEJYO F. Uremic pruritus in chronic hemodialysis patients. J Nephrol, 2008, 21(2): 161–165.
METTANG T, KREMER A E. Uremic pruritus. Kidney Int, 2015, 87(4): 685–691.
LEE H C, PARK S Y. Preliminary comparison of the efficacy and safety of needle-embedding therapy with acupuncture for atopic dermatitis patients. Evid Based Complement Alternat Med, 2019, 2019: 6937942.
WANG Z, CHEN T, LONG M, CHEN L, WANG L, YIN N, CHEN Z. Electro-acupuncture at acupoint ST36 ameliorates inflammation and regulates Th1/Th2 balance in delayed-type hypersensitivity. Inflammation, 2017, 40(2): 422–434.
LAN L, TAO J, CHEN A, XIE G, HUANG J, LIN J, PENG J, CHEN L. Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-κB pathway. Int J Mol Med, 2013, 31(1): 75–80.
GAO H, ZHANG W, WANG Y. Acupuncture treatment for 34 cases of uremic cutaneous pruritus. J Tradit Chin Med, 2002, 22(1): 29–30.
CHOU C Y, CHENG Y W, KAO M T, HUANG C C. Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant, 2005, 20(9): 1912–1915.
PHAN F A, SRILESTARI A, MIHARDJA H, MARBUN M B H. Effects of acupuncture on uremic pruritus in patients undergoing hemodialysis. J Phys Conf Ser, 2018, 1073: 062049.
KIM K H, LEE M S, CHOI S M. Acupuncture for treating uremic pruritus in patients with end-stage renal disease: a systematic review. J Pain Symptom Manage, 2010, 40(1): 117–125.
MACPHERSON H, ALTMAN D G, HAMMERSCHLAG R, LI Y, WU T, WHITE A, MOHER D; STRICTA Revision Group. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med, 2010, 3(3): 140–155.
ELMAN S, HYNAN L S, GABRIEL V, MAYO M J. The 5-D itch scale: a new measure of pruritus. Br J Dermatol, 2010, 162(3): 587–593.
FILSHIE J, WHITE A, CUMMINGS M. Medical Acupuncture: A Western Scientific Approach. 2nd Edition. London: Elsevier Ltd., 2016.
KIM J, OH H J, YOON S P. A cadaveric study of needle insertion at LI11. Acupunct Med, 2015, 33(6): 497–499.
YU C, ZHANG P, LÜ Z T, LI J J, LI H P, WU C H, GAO F, YUAN X C, ZHANG J, HE W, JING X H, LI M. Efficacy of acupuncture in itch: a systematic review and meta-analysis of clinical randomized controlled trials. Evid Based Complement Alternat Med, 2015, 2015: 208690.
WONG E L, LEUNG P C, ZHANG L. Placebo acupuncture in an acupuncture clinical trial. How good is the blinding effect?. J Acupunct Meridian Stud, 2015, 8(1): 40–43.
PFAB F, HAMMES M, BÄCKER M, HUSS-MARP J, ATHANASIADIS G I, TÖLLE T R, BEHRENDT H, RING J, DARSOW U. Preventive effect of acupuncture on histamine-induced itch: a blinded, randomized, placebo-controlled, crossover trial. J Allergy Clin Immunol, 2005, 116(6): 1386–1388.
QI Y Z. Unexpected massive cutaneous pruritus treated by acupuncture. World J Acupunct Moxibustion, 2012, 22(4): 65–66.
KARJALIAN F, MOMENNASAB M, YOOSEFINEJAD A K, JAHROMI S E. The effect of acupressure on the severity of pruritus and laboratory parameters in patients undergoing hemodialysis: a randomized clinical trial. J Acupunct Meridian Stud, 2020, 13(4): 117–123.
KUMAR K, SINGH S. Neuraxial opioid-induced pruritus: an update. J Anaesthesiol Clin Pharmacol, 2013, 29(3): 303–307.
DASHTDAR M, DASHTDAR M R, DASHTDAR B, KARDI K, SHIRAZI M K. The concept of wind in traditional Chinese medicine. J Pharmacopuncture, 2016, 19(4): 293–302.
WU J, HU Y, ZHU Y, YIN P, LITSCHER G, XU S. Systematic review of adverse effects: a further step towards modernization of acupuncture in China. Evid Based Complement Alternat Med, 2015, 2015: 432467.
PARK H, KIM K. Isolated common femoral artery injury resulting from blunt military trauma. Mil Med, 2018, 183(11–12): e758–e761.
QI Y C, XIAO X J, DUAN R S, YUE Y H, ZHANG X L, LI J T, LI Y Z. Effect of acupuncture on inflammatory cytokines expression of spastic cerebral palsy rats. Asian Pac J Trop Med, 2014, 7(6): 492–495.
PAVLOV V A, TRACEY K J. Neural circuitry and immunity. Immunol Res, 2015, 63(1): 38–57.
ZIA S, NDOYE A, LEE T X, WEBBER R J, GRANDO S A. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther, 2000, 293(3): 973–981.
KAWASHIMA K, YOSHIKAWA K, FUJII YX, MORIWAKI Y, MISAWA H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci, 2007, 80(24): 2314–2319.
PARRISH W R, ROSAS-BALLINA M, GALLOWITSCH-PUERTA M, OCHANI M, OCHANI K, YANG LH, HUDSON L, LIN X, PATEL N, JOHNSON S M, CHAVAN S, GOLDSTEIN R S, CZURA C J, MILLER E J, AL-ABED Y, TRACEY K J, PAVLOV V A. Modulation of TNF release by choline requires alpha 7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med, 2008, 14(9–10): 567–574.
DA SILVA M D, GUGINSKI G, WERNER M F, BAGGIO C H, MARCON R, SANTOS A R. Involvement of interleukin-10 in the anti-inflammatory effect of Sanyinjiao (SP6) acupuncture in a mouse model of peritonitis. Evid Based Complement Alternat Med, 2011, 2011: 217946.
CAPOBIANCO M, CASSIANO G, FURINI A, STORTI-MELO L, BONINI C, DANTAS MACHADO RL. Human interleukin 2 (IL-2) promotion of immune regulation and clinical outcomes: a review. J Cytok Bio, 2016, 1: 2.
FANG J Q, LIU F, SHAO X M, WU Y Y. Effect of electroacupuncture on carrageenan-induced inflammation, IL-1beta and TNF-alpha concentrations and their mRNA expressions in toe tissue in rats. Zhen Ci Yan Jiu, 2007, 32(4): 224–228.
PARK J Y, PARK H J, CHOI Y Y, KIM M H, KIM S N, YANG W M. Effects of acupuncture on 1-chloro-2, 4-dinitrochlorobenzene-induced atopic dermatitis. Evid Based Complement Alternat Med, 2013, 2013: 982095.
WU M, CUI J, XU D, ZHANG K, JING X, BAI W. Neuroanatomical characteristics of deep and superficial needling using LI11 as an example. Acupunct Med, 2015, 33(6): 472–477.
ERNST E, WHITE A R. Prospective studies of the safety of acupuncture: a systematic review. Am J Med, 2001, 110(6): 481–485.
TEY H L, WALLENGREN J, YOSIPOVITCH G. Psychosomatic factors in pruritus. Clin Dermatol, 2013, 31(1): 31–40.
ZASLAWSKI C, ROGERS C, GARVEY M, RYAN D, YANG C X, ZHANG S P. Strategies to maintain the credibility of sham acupuncture used as a control treatment in clinical trials. J Altern Complement Med, 1997, 3(3): 257–266.
LUND I, NÄSLUND J, LUNDEBERG T. Minimal acupuncture is not a valid placebo control in randomised controlled trials of acupuncture: a physiologist’s perspective. Chin Med, 2009, 4: 1.
Acknowledgments
The authors would like to thank the editors of Editverse (www.editverse.com) for their help in manuscript editing and formatting.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of Interest
The authors declare that there is no potential conflict of interest in this article.
Statement of Informed Consent
Informed consent was obtained from all individual participants.
Rights and permissions
About this article
Cite this article
Ardinata, D., Zain-Hamid, R., Mahadi, I.D. et al. Reduction of serum level of interleukin-2 and pruritus severity after acupuncture at Quchi (LI11) in hemodialysis patients: a placebo-controlled randomized clinical trial. J. Acupunct. Tuina. Sci. 20, 126–133 (2022). https://doi.org/10.1007/s11726-022-1299-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11726-022-1299-3
Keywords
- Acupuncture Therapy
- Point, Quchi (LI11)
- Interleukin-2
- Pain
- Pruritus
- Hemodialysis
- Randomized Controlled Trial